COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,400 Articles (22,816 medRxiv, 8,584 bioRxiv)

Most recent first Previous |  Page 150: Articles 1491-1500  | Next

From protection of sacrificial self to critical turning points and growth: Nurses experiences on the frontline during the COVID-19 pandemic.
Creedon, S., Trace, A.
10.1101/2024.11.19.24317599 — Posted: 2024-11-20
The impact of vaccination on preventing long COVID in the Omicron era: a systematic review and meta-analysis
Green, R., Marjenberg, Z., Lip, G. Y. H., Banerjee, A., Wisnivesky, J., Delaney, B. C., Peluso, M. J., Wynberg, E., Abduljawad, S.
10.1101/2024.11.19.24317487 — Posted: 2024-11-20
The impact of human behavioral adaptation stratified by immune status on COVID-19 spread with application to South Korea
Sharbayta, S. S., Jo, Y., Jung, J., Buonomo, B.
10.1101/2024.11.19.24317549 — Posted: 2024-11-20
Excess weight increases the risk for neurological and neuropsychiatric symptoms in post-COVID-19 condition: A systematic review and meta-analysis
Ronca, D. B., Mesquita, L. O., Oliveira, D. b., Figueiredo, A. C. M. G., Wen, J., Song, M., de Carvalho, K. M. B.
10.1101/2024.11.20.24317635 — Posted: 2024-11-20
The sequence and structural integrity of the SARS-CoV-2 Spike protein transmembrane domain is crucial for viral entry
Ortiz-Mateu, J., Belda, D., Aviles-Alia, A. I., Alonso-Romero, J., Garcia-Murria, M. J., Mingarro, I., Geller, R., Martinez-Gil, L.
10.1101/2024.11.19.624333 — Posted: 2024-11-20
Robust antiviral humoral immunity induced by JN.1 monovalent mRNA vaccines against a broad range of SARS-CoV-2 Omicron subvariants including JN.1, KP.3.1.1 and XEC
Uriu, K., Kaku, Y., Uwamino, Y., Fujiwara, H., Saito, F., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Sato, K.
10.1101/2024.11.20.624471 — Posted: 2024-11-20
Gut microbiome dysbiosis and immune activation correlate with somatic and neuropsychiatric symptoms in COVID-19 patients
Scalzo, P., Marshall, A., Soriano, S., Curry, K., Dulay, M., Hodics, T., Quigley, E. M., Treangen, T., Piskorz, M. M., Villapol, S.
10.1101/2024.11.18.24317428 — Posted: 2024-11-19
Low levels of neutralizing antibodies against SARS-CoV-2 KP.3.1.1 and XEC in serum from seniors in May 2024
Fossum, E., Vikse, E. L., Robertson, A. H., Wolf, A.-S., Rohringer, A., Trogstad, L., Mjaaland, S., Hungnes, O., Bragstad, K.
10.1101/2024.11.18.623742 — Posted: 2024-11-19
Clinical Features of Long COVID Patients Coinfected with Mycoplasma pneumoniae
Zhu, X., Li, Y., Wang, J., Gao, W.
10.1101/2024.11.16.24317441 — Posted: 2024-11-18
Upper Respiratory Tract Resistome exhibits SARS-CoV-2 specific antimicrobial resistance patterns
Tomar, S. S., Khairnar, K.
10.1101/2024.11.14.24317312 — Posted: 2024-11-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).